Black Diamond Therapeutics (BDTX) Earnings Date, Estimates & Call Transcripts $2.75 -0.10 (-3.51%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.80 +0.05 (+1.82%) As of 08/29/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Black Diamond Therapeutics Earnings Summary Black Diamond Therapeutics posted Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.19, which topped the consensus estimate of -$0.25 by $0.06. With a trailing EPS of $0.23 and a P/E Ratio of 11.96, Black Diamond Therapeutics' earnings are expected to grow next year, from ($1.30) to ($1.22) per share. Upcoming Q3 Earnings DateNov. 4Before Market OpensEstimatedConsensus EPS (Aug. 7) -$0.25 Actual EPS (Aug. 7) -$0.19 Beat By $0.06 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SEC FilingBDTX Upcoming EarningsBlack Diamond Therapeutics' next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules. Powered by Get Black Diamond Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Black Diamond Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataBDTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Black Diamond Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.32$0.92$0.30Q2 20252-$0.33-$0.25-$0.29Q3 20252-$0.25-$0.24-$0.25Q4 20252-$0.24-$0.19-$0.22 FY 2025 8 -$1.14 $0.24 -$0.45 Q1 20262-$0.25-$0.22-$0.24Q2 20262-$0.26-$0.23-$0.25Q3 20262-$0.26-$0.23-$0.25Q4 20262-$0.27-$0.24-$0.26 Black Diamond Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2025(Estimated)--------8/7/2025Q2 2025-$0.25-$0.19+$0.06-$0.19--3/6/2025Q4 2024-$0.31-$0.28+$0.03-$0.28--11/5/2024--$0.37-$0.28+$0.09-$0.28--8/6/2024Q2 2024-$0.39-$0.36+$0.03-$0.36--5/9/2024Q1 2024-$0.44-$0.35+$0.09-$0.35--3/12/2024Q4 2023-$0.47-$0.34+$0.13-$0.34--11/6/2023Q3 2023-$0.49-$0.45+$0.04-$0.45-- Black Diamond Therapeutics Earnings - Frequently Asked Questions When is Black Diamond Therapeutics' earnings date? Black Diamond Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on BDTX's earnings history. Did Black Diamond Therapeutics beat their earnings estimates last quarter? In the previous quarter, Black Diamond Therapeutics (NASDAQ:BDTX) reported ($0.19) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.06. Learn more on analysts' earnings estimate vs. BDTX's actual earnings. How can I view Black Diamond Therapeutics' earnings report? Black Diamond Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much profit does Black Diamond Therapeutics generate each year? Black Diamond Therapeutics (NASDAQ:BDTX) has a recorded net income of -$69.68 million. BDTX has generated $0.23 earnings per share over the last four quarters. What is Black Diamond Therapeutics' price-to-earnings ratio? Black Diamond Therapeutics (NASDAQ:BDTX) has a trailing price-to-earnings ratio of 11.96. What is Black Diamond Therapeutics' EPS forecast for next year? Black Diamond Therapeutics' earnings are expected to grow from ($1.30) per share to ($1.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Kura Oncology Earnings Results Siga Technologies Earnings Results Bicara Therapeutics Earnings Results Vir Biotechnology Earnings Results Relay Therapeutics Earnings Results Keros Therapeutics Earnings Results MeiraGTx Earnings Results Maravai LifeSciences Earnings Results Tyra Biosciences Earnings Results Organogenesis Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NASDAQ:BDTX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
